Vimarsana
Biggest News Aggregation in the World

Page 32 - 775 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 775. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 775 Today - Breaking & Trending Today

FOXNEWS FOX and Friends Saturday October 2, 2021 11:44:00 - Vimarsana News

FOXNEWS FOX and Friends Saturday October 2, 2021 11:44:00

>> you got it right. will: you did? i'm impressed by myself. that drug, that drug apparently has a 50% reduction in hospitalizations when it comes to code. it's oral, i believe, pill that you take. but what is interesting is studies out of harvard, for example, if i mentioned the drug that shall not be mentioned ivermectin that drug has reduced hospitalizations by as much as 80%. and that drug by the way is generic and not as much money to be made as prescribing ivermectin why this is a break through with merck's drug? >> i like the way merck studied this drug i like 775 kids looked at late st...

Related Topics:
No related topics available
BBCNEWS BBC News October 2, 2021 02:02:00 - Vimarsana News

BBCNEWS BBC News October 2, 2021 02:02:00

Of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at—risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eight patients who were given a placebo — or dummy pill — later died of covid, but there were no deaths in the group taking t...

CNN Don Lemon Tonight October 2, 2021 06:45:00 - Vimarsana News

CNN Don Lemon Tonight October 2, 2021 06:45:00

Pills twice a day. so you might take 40 pills or so. but it works in terms of reducing the hospitalizations by half. and in the control group, this was 775 patients with -- with sars 2 coronavirus. there were eight deaths in the control, and none in the treatment group. so it's still not a huge study. but it was so compelling that the data safety monitoring board said, stop, we -- this -- this looks like it's really promising, and i think on this basis, merck and company will file for emergency-use authorization. um, it has limits. um, it -- you have to take it very early on in the course of t...

BBCNEWS BBC News October 1, 2021 23:02:00 - Vimarsana News

BBCNEWS BBC News October 1, 2021 23:02:00

This is the first covid pill, trial results suggest taking cut hospitalisations or deaths by half. cut hospitalisations or deaths b half. , ., by half. the news of the efficacy _ by half. the news of the efficacy of _ by half. the news of the efficacy of this - by half. the news of the| efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. fda imminently. the data are impressive-— fda imminently. the data are impressive. pills were g...

KGO ABC World News Tonight With David Muir October 1, 2021 22:37:00 - Vimarsana News

KGO ABC World News Tonight With David Muir October 1, 2021 22:37:00

Announcing that trials show its new drug, molnupiravir, may cut the risk of hospitalization or death in half. >> this is a pill you can take at home and will significantly reduce the risk that you either ultimately are hospitalized or more importantly, that you would ever face the unfortunate outcome of death. >> reporter: the drug consists of 4 pills taken every 12 hours for 5 days, beginning soon after testing positive. the trial included 775 patients with mild to moderate covid who had at least one risk factor for severe disease. after 29 days, no deaths reported in patients who received th...